[15972] in Public-Access_Computer_Systems_Forum
BioTechnology Alert for Monday
daemon@ATHENA.MIT.EDU (mromnauuuwd)
Sat Jul 23 18:59:25 2005
message-id: <3d1301c58fda$168fea20$e26c90e2@YCFEEU>
From: "mromnauuuwd" <mromnauuuwd@tarbostune.com>
To: <manis@mit.edu>, <pacs@mit.edu>
Date: Sat, 23 Jul 2005 18:58:49 -0500
MIME-Version: 1.0
Content-Type: multipart/alternative;
boundary="----=_NextPart_000_3D10_01C58FB8.8F7E4A20"
This is a multi-part message in MIME format.
------=_NextPart_000_3D10_01C58FB8.8F7E4A20
Content-Type: text/plain;
charset="iso-8859-1"
Content-Transfer-Encoding: quoted-printable
------=_NextPart_000_3D10_01C58FB8.8F7E4A20
Content-Type: text/html;
charset="iso-8859-1"
Content-Transfer-Encoding: quoted-printable
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<HTML>
<BODY bgColor=3D#ffffff>
<DIV><FONT face=3DArial size=3D2>
<DIV><SPAN class=3Dt><STRONG><FONT color=3D#ff0000 size=3D3>BioTechnology
News..... Monday's Watch.. Radar Alert</FONT></STRONG></SPAN></DIV>
<DIV><SPAN class=3Dt><SPAN class=3Dt><STRONG><FONT size=3D3>Pacific Sunset =
Investments
Inc.</FONT></STRONG></SPAN></SPAN></DIV>
<DIV><SPAN class=3Dt><SPAN class=3Dt><STRONG><FONT
size=3D3>PSiV</FONT></STRONG></SPAN></SPAN></DIV>
<DIV><SPAN class=3Dt><SPAN class=3Dt><STRONG><FONT
size=3D3></FONT></STRONG></SPAN></SPAN> </DIV>
<DIV><SPAN class=3Dt><SPAN class=3Dt><STRONG><FONT size=3D3>How many times =
have you
heard about this????</FONT></STRONG></SPAN></SPAN></DIV>
<DIV><SPAN class=3Dt><FONT size=3D3>adverse drug reactions accounted for =
more than
2.2 million serious cases and over <STRONG>100,000 deaths</STRONG>,
<STRONG><FONT color=3D#ff0000>Given a choice, if possible, wouldn't you =
want a
test to make sure you didn't suffer a deadly reaction to a prescribed drug =
first?</FONT></STRONG></FONT></SPAN></DIV>
<DIV><SPAN class=3Dt><FONT size=3D3></FONT></SPAN> </DIV>
<DIV><SPAN class=3Dt><STRONG><FONT
size=3D3>PSIV***PSIV***PSIV***PSIV***PSIV***PSIV***PSIV***PSIV***PSIV***PSI=
V</FONT></STRONG></SPAN></DIV>
<DIV><SPAN class=3Dt>A study published in the Journal of the American =
Medical
Association reported that adverse drug reactions accounted for more than =
2.2
million serious cases and over <STRONG>100,000 deaths</STRONG>, making =
adverse
drug reactions (ADRs) one of the leading causes of hospitalization and =
death in
the United States. </SPAN></DIV>
<DIV><SPAN class=3Dt><STRONG><FONT =
size=3D3></FONT></STRONG></SPAN> </DIV>
<DIV align=3Dcenter><SPAN class=3Dt><STRONG><FONT color=3D#ff0000 =
size=3D3>Breaking News
for Pacific Sunset Investments</FONT></STRONG></SPAN></DIV>
<DIV><SPAN class=3Dt><STRONG><FONT =
size=3D3></FONT></STRONG></SPAN> </DIV>
<DIV align=3Dcenter><SPAN class=3Dt><STRONG><FONT size=3D3>Pacific Sunset =
Investments
Completes Gen ID Acquisition</FONT></STRONG></SPAN></DIV>
<DIV align=3Dleft><SPAN class=3Dt>HUNTINGTON BEACH, Calif.--(BUSINESS =
WIRE)--May 20,
2005--Pacific Sunset Investments, Inc. ("Pacific Sunset") (OTC:PSiV =
announced
that it has completed its acquisition of Gen-ID Lab Services, LLC, a =
California
limited liability corporation specializing in Single Nucleotide =
Polymorphism
analysis data. In addition, the board of directors of Pacific Sunset has
appointed Douglas Freedman to its board of directors with experience in
marketing. Additionally, the company has appointed Dr. Steve N. Slilaty, =
Ph.D.,
to head an Advisory Board to assist the company with reviewing new =
alternatives
in the "SNP" field of technology. </SPAN></DIV>
<DIV align=3Dleft><SPAN class=3Dt></SPAN> </DIV>
<DIV align=3Dleft><SPAN class=3Dt><STRONG>Gen ID will provide "SNP" =
(Single
Nucleotide Polymorphism) analysis data. The results of SNP analysis =
provide
physicians with a more enlightened choice of drugs and they will also be =
able to
predict the effectiveness of the drugs for individual patients. The use of =
an
SNP test to help treat childhood leukemia is currently being used by =
doctors and
hospitals in the United States.</STRONG> </SPAN></DIV>
<DIV align=3Dleft><SPAN class=3Dt><STRONG></STRONG></SPAN> </DIV>
<DIV align=3Dleft><SPAN class=3Dt><STRONG>Dr. Steve Slilaty</STRONG> is =
President
and Chief Scientific Officer of Advanomics Corporation, a leading-edge
biotechnology company focusing on the identification of disease related
molecular targets using advanced transriptomics technologies, which he =
recently
developed. Dr. Slilaty also is an Adjunct Professor at the Universite du =
Quebec
in the department of Microbiology and Biotechnology. Dr. Slilaty has =
founded
three biotechnology companies, Advanomics Corporation, Quantum =
Biotechnologies
Inc. (now known as Qbiogene Inc.) and Geneomics One Corporation. In =
addition,
Dr. Slilaty is one of the pioneers of Gene Therapy, having developed the =
first
Gene Transfer system in 1983. </SPAN></DIV>
<DIV align=3Dleft><SPAN class=3Dt></SPAN> </DIV>
<DIV align=3Dleft><SPAN class=3Dt><STRONG>(This is a partial clip of the =
news.
We suggest you go read the whole release. Our opinion is, this is
important technology. Go to yahoo or any financial site and read the =
news)</STRONG></SPAN></DIV>
<DIV align=3Dleft><SPAN class=3Dt></SPAN> </DIV>
<DIV align=3Dleft><SPAN class=3Dt>
<DIV><STRONG>CONCLUSION:</STRONG></DIV>
<DIV><SPAN class=3Dt><FONT size=3D3>adverse drug reactions accounted for =
more than
2.2 million serious cases and over <STRONG>100,000 deaths</STRONG>,
Doesn't this say it all? </FONT></SPAN></DIV>
<DIV><SPAN class=3Dt><FONT =
size=3D3></FONT></SPAN> </DIV></SPAN></DIV>
<DIV align=3Dleft><SPAN class=3Dt>
<DIV align=3Dcenter><FONT color=3D#ff0000 size=3D3><STRONG> A company =
to
watch!</STRONG></FONT></DIV>
<DIV align=3Dcenter> </DIV>
<DIV align=3Dcenter>AGGRESSIVE INVESTORS TAKE NOTE NOW! <BR><STRONG>PUT =
<SPAN
class=3Dt><SPAN class=3Dt><STRONG><FONT size=3D3>Pacific Sunset =
Investments Inc.
PSiV</FONT></STRONG></SPAN></SPAN></STRONG><BR>ON YOUR RADAR SCREENS =
NOW,<BR>AND
WATCH THIS COMPANY STARTING NOW</DIV></SPAN></DIV>
<DIV align=3Dleft><SPAN class=3Dt></SPAN> </DIV>
<DIV align=3Dleft><SPAN class=3Dt>
<P align=3Dleft><FONT face=3DArial color=3Dblack size=3D1><SPAN
style=3D"COLOR: black"></SPAN></FONT> </P>
<P align=3Dleft><FONT face=3DArial color=3Dblack size=3D1><SPAN
style=3D"COLOR: black">This email was prepared based upon public =
information
believed to be reliable. The information contained herein is not =
guaranteed
by us to be accurate, and should not be considered to be =
all-inclusive. The
company that we discussed in this opinion has not approved the
statements made in this opinion. This opinion contains forward-looking
statements that involve risks and uncertainties. This material is =
for
informational purposes only and should not be construed as an offer or
solicitation of an offer to buy or sell securities. Be aware We =
are not a
licensed broker, broker dealer, market maker, investment banker, =
investment
advisor, analyst or underwriter. Please consult a broker before purchasing =
or
selling any securities mentioned herein. <STRONG>Be aware that we are =
paid
for these advertisements</STRONG>. We have been compensated by third =
party
shareholders or with cash from the company on behalf of one or more of the =
companies mentioned in this opinion. Liquid Assetts is the third party.
We have been compensated two hundred thousand free trading =
shares
for advertising psiv. We do intend to sell all shares. =
In
addition to any compensation mentioned above, additional compensation can =
be
equal to ten percent of any newly issued or registered securities of the
profiled companies. Our affiliates, officers, directors and employees =
may
also have bought or may buy the shares discussed in this opinion and may =
profit
in the event those shares rise in value. We will not advise as to =
when it
decides to sell and does not and will not offer any opinion as to when =
others
should sell; each investor must make that decision based on his or her =
judgment
<STRONG>If you are not a savy investor and are not familiar with the =
violatile
movements in many Bulletin Board and pinksheet stocks, we suggest you sit =
back
and watch, you can lose all your money very quickly.permanently stop =
receiving thisNewsletter, please use our secure One-Step
Safe Un-Sub-scribe: Send a blank e-mail with "NoThanks" in the
sub-ject line to nothanks@peitme.com For any questions, comments or
complaints about receiving this newsletter; please write to:
e-Broadcast 6 Eftute Ave. Kingston 10 Jamaica WI
</STRONG></SPAN></FONT></P></SPAN></DIV></FONT></DIV></BODY></HTML>
------=_NextPart_000_3D10_01C58FB8.8F7E4A20--
